Microalbuminuria and hypertensive retinopathy among newly diagnosed nondiabetic hypertensive adult Nigerians by Busari, OA et al.
436 Nigerian Journal of Clinical Practice • Oct-Dec 2011 • Vol 14 • Issue 4
Microalbuminuria and hypertensive retinopathy 
among newly diagnosed nondiabetic hypertensive 
adult Nigerians
OA Busari, OG Opadijo1, AB Omotoso2
Department of Medicine, Federal Medical Centre, Ido-Ekiti, 1Ladoke Akintola University of Technology, Osogbo, 
2University of Ilorin, Ilorin, Nigeria
Address for correspondence:
Dr. Busari O. A.,
Department of Medicine Cardiology Unit, Federal Medical Centre, 
Ido-Ekiti, Nigeria.  
E-mail: olubusari@yahoo.com
Introduction
High blood pressure (HBP) is a common disease globally. 
It is a major risk factor for cardiovascular disease, stroke, 
chronic renal failure, and peripheral vascular disease. 
Although there is no recent concise data on prevalence of 
HBP in Nigeria, it is estimated that about 17 to 20% or more 
of adult Nigerians have HBP.[1,2] Microalbuminuria (MA) 
has been described in Nigerians with HBP. It is defined as 
urinary excretion rate of 30 to 300 mg/day or as urinary 
albumin creatinine ratio of 3 to 30 mg/g.[3] MA is a marker of 
vascular damage and has prognostic implications in HBP. [4] 
Biensenbach and Zazgornik reported a high prevalence of 
hypertensive retinopathy (HRP) in hypertensive patients 
with persistent albuminuria.[5]
There is a paucity of data on whether the presence of 
MA increases the risk of hypertensive retinal damage in 
adult Nigerians with HBP. The objective of this study was 
to determine if the presence of MA increases the risk of 
hypertensive retinal damage in nondiabetic adult Nigerians 
with hypertension.
Materials and Methods
The study was conducted in the cardiology clinic of the 
University of Ilorin Teaching Hospital between October 
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2003 and September 2004. Ninety six consecutive newly 
diagnosed hypertensive patients attending were recruited. 
Main inclusion criteria were newly diagnosed HBP for which 
antihypertensive	medications	had	never	been	used;	age	≥18	
years; normal sediments, no proteinuria with conventional 
dipstick test; and both oral and written consent to 
participate in the study. There was also the same number 
of age- and sex-matched normotensive controls. Some of 
the exclusion criteria were diabetes mellitus (fasting plasma 
glucose	≥7.0	mmol/l	or	use	of	oral	hypoglycemic	agents	and/
or insulin), renal or endocrine disease, obesity, congestive 
heart failure, and abnormal liver function tests. Renal and 
endocrine diseases were excluded mostly by history and 
physical examination, and by laboratory investigations such 
as urine microscopy for urinary sediments, urine culture, 
renal ultrasound scanning, and serum renal biochemistry 
including creatinine clearance. The study was done in 
accordance with the Declaration of Helsinki and the 
protocol approved by the Ethical and Research Committee 
of the hospital.
Clinical evaluation, definition, and measurements
All participants underwent a detailed history and a 
thorough physical examination. Blood pressures were 
measured using mercury column sphygmomanometer 
and cuff of appropriate size. A standardized protocol 
was followed, in which systolic (SBP) and diastolic 
(DBP) blood pressures were measured on the left arm 
after participants had been seated for at least 5 minutes. 
Three measurements were done at least 5 minutes apart 
and the mean value was used for the study. HBP was 
defined	as	SBP	≥140	mmHg	and/or	DBP	≥90	mmHg,	or	
use of antihypertensive medications.[6] Ophthalmologic 
examination of the fundi was done after dilating the pupils 
with 0.5% tropicamide. HRP was graded according to 
Keith-Wagener-Baker’s classification.[7]
Microalbuminuria testing
Traditional urinary dipsticks are insensitive at detecting 
albuminuria less than 300 mg/day. MA was determined 
using the Micra Test II test strips (Boehringer Mannheim, 
Mannheim, Germany) urine dipsticks. This test strip 
has been found to be the fastest, reliably accurate, and, 
relatively, the cheapest way to screen patients for the 
presence of MA.[8] There are four color blocks on the test 
strip corresponding to negative (or 0), 20, 50, and 100 mg/l 
of albumin. The test was done on three consecutive first-
morning voided urine samples of both patients and controls. 
MA was considered to be present when two of the three 
urine samples tested produce a reaction color corresponding 
to 20 mg/l or more. The mean value of the MA was also 
recorded for each participant.
Data analysis
The data collected were analyzed with SPSS 10.5 software. 
Percentages and proportions were used to describe 
categorical variables, while means and standard deviations 
were used for numerical variables. Chi-square and Student’s 
t test were used to analyze differences between variables 
as appropriate. P<0.05 was taken as indicating statistical 
significance.
Results
There were 96 hypertensive patients studied and the same 
number of age- and sex-matched normotensive controls. 
The patients comprised of 52 (54.2%) males and 44 (45.8%) 
females with a male : female ratio of 1.2:1. The mean (±SD) 
age for patients was 49.7 ± 12.7 years. MA was present in 
31 (32.3%) of the patients and 6 (6.3%) of the controls. The 
presence or otherwise of MA was used to divide the patients 
into the following two subgroups: hypertensive patients with 
or without MA. The mean (±SD) ages of patients with and 
without MA were 52.5 ± 11.9 years and 48.3 ± 13.0 years, 
respectively. There was no statistically significant difference 
between the mean ages (P = 0.14). The blood pressure 
characteristics of the patients and the controls are shown 
in Tables 1 and 2. The DBP (P = 0.03) and Mean Arterial 
Pressure (P = 0.01) were statistically higher in hypertensive 
patients with MA than in their counterparts without MA.
The prevalence of HRP in the patients and the controls are 
Table 1: Blood pressure and hypertensive retinopathy characteristics of patients and controls
Patients Controls P
M (n = 52) F (n = 44) T (n = 96) M (n = 49) F (n = 47) T (n = 96)
Mean SBP 164.5 ± 14.2 155.5 ± 15.1 160.0 ± 15.0 132.4 ± 9.7 125.6 ± 8.2  129.0 ± 10.0 <0.001
Mean DBP 111.5 ± 10.1 103.3 ± 11.8 107.4 ± 10.5 82.1 ± 5.9 78.3 ± 7.1 80.2 ± 6.9 <0.001
Mean PP 53.0 ± 10.7 52.2 ± 12.9 52.6 ± 8.6 50.3 ± 6.5 47.3 ± 7.6 48.8 ± 7.1 0.02
Mean MAP 129.2 ± 12.5 120.7 ± 10.6 124.9 ± 11.5 98.9 ± 8.8 94.1 ± 9.1 96.5 ± 8.9 0.002
Normal 21 (40.4%) 26 (59.1%) 47 (49.0%) 43 (87.8%) 44 (93.6%) 87 (90.6%) <0.001
Grade I 13 (25.0%) 8 (18.2%) 21 (21.9%) 5 (10.2%) 3 (6.4%) 8 (8.3%) 0.005
Grade II 11 (21.2%) 8 (18.2%) 19 (19.8%) 1 (2.0%) 1 (1.0%) <0.001
Grade III 5 (9.6%) 2 (4.5%) 7 (7.3%)
Grade IV 2 (3.8%) 2 (2.1%)
SBP = Systolic blood pressures, DBP = Diastolic blood pressures, PP = Pulse pressure, MAP = Mean arterial pressure
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depicted in Table 3. HRP was significantly more frequent in 
the patients than in the normotensive controls (P<0.001). 
In contrast to the findings in the patients [Table 3], only 
one (11.1%) of the controls had a grade of HRP worse 
than Grade I. The subgroup of patients with MA was more 
likely to have HRP than patients without MA (71% vs 
37%, P = 0.001). Significant HRP, i.e., Grades III-IV, was 
more common in patients with MA than in those without 
MA (22.6% vs 1.5%). Only one hypertensive patient had 
papilledema (Grade IV HRP), and was of the subgroup 
with MA.
Discussion
The prevalence of MA in patients with HBP found in this 
study is high (32.2%). This prevalence translates to one in 
every three Nigerians with HBP likely to have MA. It is a 
report that should be taken very serious if the prognostic 
implications of MA are anything to go by. However, this figure 
is different from 17.4% prevalence reported in a Nigerian 
study by Akinsola et al.[9] The difference might be partly due 
to separate cut-off values used for MA. The two studies used 
the same Micra Test II test strips (Boehringer Mannheim, 
Mannheim, Germany) to determine MA but different cut-off 
values. We used 20 µg/min, while Akinsola et al. used 50 µg/
min. Other differences that might be worthy of note in these 
studies are patient selection criteria. To a large extent, our 
study prevalence of MA falls well within a range of figures 
(4.7%-40%) reported in many previous studies.[10,11]
Our patients with MA were significantly more likely to have 
HRP than their counterparts without MA. Furthermore, this 
subset of hypertensive patients tended to have worse grades 
of HRP. This is similar to report from other centers. [9,12] 
From the current findings, MA appears to be an indicator 
of advanced HRP. The association between MA and 
HRP might not be unconnected, at least in part, with the 
higher blood pressure in patients with MA. Although, SBP 
appears to have remained a more consistent determinant 
of MA in hypertensives, our report indicated otherwise. 
We found that DBP and MAP were significantly higher in 
MA hypertensive patients. This finding is consistent with a 
report by de-la-Sierra et al.[13] and findings of a large Chinese 
study.[14] Some studies have suggested that MA may precede 
the progression to higher blood pressure stages.[15] Although 
MA has been viewed as a marker of vascular dysfunction 
in both the kidneys and systemic vasculature in particular, 
it is not unlikely that the vascular damage is a generalized 
phenomenon.[4]
Conclusions
This study found a high prevalence (32%) of MA, which 
is a marker of vascular damage. It also showed that MA is 
characterized by increased prevalence and severity of HRP 
in nondiabetic Nigerians with HBP. Thus, the presence of 
MA clearly defines a subset of hypertensive patients with 
increased risk of HRP. These patients should be routinely 
assessed for HRP with simple ophthalmologic examination 
which though is the ideal practice, but not commonly done 
in most resource-poor developing settings. I recommend 
that screening of MA should be mainstreamed into routine 
investigation and follow-up of patients with HBP.
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